Cost Drivers in Patients with Classic Congenital Adrenal Hyperplasia (CAH)

MFarrar , C O’Donoghue , E Paiewonsky , C Yonan , R Nathan , D Pfeffer , V Tiwari , P Shripathi , P Russo

Abstract

Classic CAH is a rare condition characterized by cortisol deficiency and androgen excess, typically requiring treatment with supraphysiologic doses of glucocorticoids. This study evaluated the costs and identified key cost drivers for classic CAH in the United States (US).

More Publications

Impact of Acne Vulgaris and Sarecycline on Social/Emotional Functioning and Daily Activities: PROSES Study

Emmy Graber , Hilary E. Baldwin , Richard G. Fried , Evan A. Rieder , Adelaide A. Hebert , James Del Rosso , Leon Kircik , Linda Stein Gold , Julie C. Harper , Andrew F. Alexis , Siva Narayanan , Volker Koscielny , Ismail Kasujee

Feb, 2024

Journal of Drugs in Dermatology (JDD)

Semaglutide and Obesity: Real-World Clinical Applications and Outcomes

Swati Sucharita Dash , Merlin Roshma Sherin , Debalina Das , Guruprasad KS Rao

Mar, 2024

International Journal of Medical Science Research and Practice

Effects of clomiphene citrate and anastrozole as a combination therapy for hypogonadism – A systematic review and meta-analysis.

Padmashobana Bagavathithasan , Swati Sucharita Dash , Lakshmi Venkatachalam , Vaishali Amol Shetye , Shashwati Pankaj , Jignesh Bhate , Guruprasad Rao KS